🇺🇸 FDA
Patent

US 8741937

Gamma glutamyl transpeptidase inhibitors and methods of use

granted A61KA61K31/433

Quick answer

US patent 8741937 (Gamma glutamyl transpeptidase inhibitors and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/433